Trials / Completed
CompletedNCT01768013
The Pharmacokinetics of LEO 90105 (Calcipotriol Hydrate Plus Betamethasone Dipropionate) in Japanese Subjects With Extensive Psoriasis Vulgaris
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 13 (actual)
- Sponsor
- LEO Pharma · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The pharmacokinetics of LEO 90105 (calcipotriol hydrate plus betamethasone dipropionate) in Japanese subjects with extensive psoriasis vulgaris.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LEO 90105 | Once daily for four weeks |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2013-01-15
- Last updated
- 2025-03-12
- Results posted
- 2013-12-30
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT01768013. Inclusion in this directory is not an endorsement.